Novel Drug Targets with Traditional Herbal Medicines for Overcoming Endometriosis

Mert Ilhan; Fatma Tuğçe Gürağaç Dereli; Esra Küpeli Akkol

doi:10.2174/1567201816666181227112421

Novel Drug Targets with Traditional Herbal Medicines for Overcoming Endometriosis

Mert Ilhan, Fatma Tuğçe Gürağaç Dereli, Esra Küpeli Akkol

Current drug delivery · 2018 · vol. 16(5) , pp. 386–399 · doi:10.2174/1567201816666181227112421 · PMID:30588884 · PMC6637095 · W2906942394

review OA: gold CC0 ⤵ 26 in-corpus citations

📄 Open PDF View on OpenAlex View on PubMed View at publisher

⚙ AI-generated summary by claude@2026-06, 2026-06-07 ⓘ

This review describes the pharmacological activity of medicinal plants and their active ingredients for discovering multitargeted drug molecules to treat endometriosis, addressing limitations of current therapies.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Endometriosis is a disease in which the lining of the endometrium is found outside of the uterus. Recent medical treatments for endometriosis have adverse effects, limiting their long-term use. Furthermore, the recurrence of the disease after the cessation of therapy is quite common, and most patients need to continue treatment to maintain a hypoestrogenic environment till conception. Notwithstanding recent advances in computational and chemical practices, traditional medicines are considered the most consistent sources for the discovery of new drugs. Numerous medicinal plants and plantderived compounds have been tested against gynecological disorders, mainly endometriosis. This review aimed to describe the pharmacological activity profile of the medicinal plants and their active ingredients and draw attention to the discovery of multitargeted drug molecules for rational therapy.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Endometriosis Phytotherapy Animals Endometriosis Endometriosis Endometriosis Female Humans Medicine, Traditional Phytochemicals Phytochemicals Plants, Medicinal

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (100)

Cited by (26)

Source provenance

europepmc: last seen: 2026-06-11T06:19:48.454388+00:00
openalex: last seen: 2026-06-10T17:14:06.276822+00:00
pubmed: last seen: 2026-05-13T22:19:25.021412+00:00

License: CC0 · commercial use OK

[1] A Botanical Extract from Channel Flow Inhibits Cell Proliferation, Induces Apoptosis, and Suppresses CCL5 in Human Endometriotic Stromal Cells1 via openalex

[2] ACUPUNCTURE IMPROVES THE EFFECTS OF CHINESE HERBAL MEDICINE IN TREATING ENDOMETRIOSIS MODEL RATS via openalex

[3] Advances in the management of endometriosis: an update for clinicians via openalex

[4] Advantages of the association of resveratrol with oral contraceptives for management of endometriosis-related pain via openalex

[5] A gonadotropin-releasing hormone agonist versus a low-dose oral contraceptive for pelvic pain associated with endometriosis via openalex

[6] A mixture of St. John's wort and sea buckthorn oils regresses endometriotic implants and affects the levels of inflammatory mediators in peritoneal fluid of the rat: A surgically induced endometriosis model via openalex

[7] Anastrazole and oral contraceptives: a novel treatment for endometriosis via openalex

[8] Angiogenesis and antiangiogenic therapy in endometriosis via openalex

[9] Angiogenic activity and IL‐8 concentrations in peritoneal fluid and sera in endometriosis via openalex

[10] Angiogenic Factors in Endometriosis via openalex

[11] Angiostatic agents prevent the development of endometriosis-like lesions in the chicken chorioallantoic membrane via openalex

[12] Anti‐Angiogenic Alternative and Complementary Medicines for the Treatment of Endometriosis: A Review of Potential Molecular Mechanisms via openalex

[13] Anti-angiogenic effects of green tea catechin on an experimental endometriosis mouse model via openalex

[14] Anti-endometrial IgM autoantibodies in endometriotic patients: a preliminary study. via openalex

[15] Antiproliferative and proapoptotic effects of epigallocatechin gallate on human leiomyoma cells via openalex

[16] A pilot study to evaluate the relative efficacy of endometrial biopsy and full curettage in making a diagnosis of endometriosis by the detection of endometrial nerve fibers via openalex

[17] Apoptosis and endometriosis via openalex

[18] A prospective study of dietary fat consumption and endometriosis risk via openalex

[19] Association between endometriosis and cancer: A comprehensive review and a critical analysis of clinical and epidemiological evidence via openalex

[20] Baicalein reduces endometriosis by suppressing the viability of human endometrial stromal cells through the nuclear factor-κB pathway in vitro via openalex

[21] Behaviour of Cytokine Levels in Serum and Peritoneal Fluid of Women with Endometriosis via openalex

[22] Biomarkers of endometriosis via openalex

[23] Chinese herbal medicine for endometriosis via openalex

[24] Curcumin arrests endometriosis by downregulation of matrix metalloproteinase-9 activity. via openalex

[25] Curcumin as anti-endometriotic agent: Implication of MMP-3 and intrinsic apoptotic pathway via openalex

[26] Curcumin Attenuates TNF‐α‐induced Expression of Intercellular Adhesion Molecule‐1, Vascular Cell Adhesion Molecule‐1 and Proinflammatory Cytokines in Human Endometriotic Stromal Cells via openalex

[27] Curcumin delays endometriosis development by inhibiting MMP-2 activity. via openalex

[28] Curcumin inhibits endometriosis endometrial cells by reducing estradiol production. via openalex

[29] Cytokine profiles in serum and peritoneal fluid from infertile women with and without endometriosis via openalex

[30] Density of small diameter sensory nerve fibres in endometrium: a semi-invasive diagnostic test for minimal to mild endometriosis via openalex

[31] Development and prevention of postsurgical adhesions in a chimeric mouse model of experimental endometriosis via openalex

[32] Differences in characteristics among 1,000 women with endometriosis based on extent of disease via openalex

[33] Different types of small nerve fibers in eutopic endometrium and myometrium in women with endometriosis via openalex

[34] Effect of interferon α-2b on endometrioma cells in vitro via openalex

[35] Effect of Notchi kudineer (Vitex negundo aqueous extract) on surgically induced Endometriosis in Sprague Dawley rats via openalex

[36] Efficacy of anti-tumor necrosis factor therapy in the treatment of spontaneous endometriosis in baboons via openalex

[37] Elevated ghrelin levels in the peritoneal fluid of patients with endometriosis: associations with vascular endothelial growth factor (VEGF) and inflammatory cytokines via openalex

[38] Elevated serum levels of endometrial secretory protein PP14 in patients with advanced endometriosis via openalex

[39] Emerging role of genomics in endometriosis research via openalex

[40] Endometrial nerve fibers in women with endometriosis, adenomyosis, and uterine fibroids via openalex

[41] Endometriosis: A genetic disease via openalex

[42] Endometriosis and its treatment with danazol or lupron in relation to ovarian cancer. via openalex

[43] Endometriosis and the neoplastic process via openalex

[44] Endometriosis: An Overview of the Disease and Its Treatment via openalex

[45] Endometriosis: novel etiopathogenetic concepts and clinical perspectives via openalex

[46] Endometriosis: Treatment Strategies via openalex

[47] Epigallocatechin-3-gallate inhibits estrogen-induced activation of endometrial cells in vitro and causes regression of endometriotic lesions in vivo via openalex

[48] ESHRE guideline for the diagnosis and treatment of endometriosis via openalex

[49] Estroprogestin vs. gonadotrophin agonists plus estroprogestin in the treatment of endometriosis-related pelvic pain: a randomized trial via openalex

[50] Eutopic endometrium from women with endometriosis does not exhibit neurotrophic properties via openalex

[51] Evaluation and management of women with endometriosis via openalex

[52] Evaluation of endometrial biomarkers for semi-invasive diagnosis of endometriosis via openalex

[53] Evolution of medical treatment for endometriosis: back to the roots? via openalex

[54] Experimental endometriosis reduction in rats treated with Uncaria tomentosa (cat's claw) extract via openalex

[55] Experimental endometriosis remission in rats treated with Achillea biebersteinii Afan.: histopathological evaluation and determination of cytokine levels via openalex

[56] Expression of Serum Human Leukocyte Antigen and Growth Factor Levels in a Greek Family With Familial Endometriosis via openalex

[57] Ginsenoside Rg3 in combination with surgery in patients with stage III-IV endometriosis: a clinical control trial via openalex

[58] High density of small nerve fibres in the functional layer of the endometrium in women with endometriosis via openalex

[59] High ω-3:ω-6 fatty acid ratios in culture medium reduce endometrial-cell survival in combined endometrial gland and stromal cell cultures from women with and without endometriosis via openalex

[60] Iconography : Curcumin and endometriosis: Review on potential roles and molecular mechanisms via openalex

[61] Immunobiology of endometriosis via openalex

[62] Impact of endometriosis on quality of life: A pilot study via openalex

[63] Impact of endometriosis on women's health: comparative historical data show that the earlier the onset, the more severe the disease via openalex

[64] Laparoscopic Management of Patients with Endometriosis and Chronic Pelvic Pain via openalex

[65] Letrozole and Curcumin Loaded-PLGA Nanoparticles: A Therapeutic Strategy for Endometriosis via openalex

[66] Letrozole and norethisterone acetate in colorectal endometriosis via openalex

[67] Matrix Metalloproteinases and Endometriosis via openalex

[68] Natural therapies assessment for the treatment of endometriosis via openalex

[69] Nonsteroidal anti-inflammatory drugs for pain in women with endometriosis via openalex

[70] Novel Therapies Targeting Endometriosis via openalex

[71] Oxidative stress and endometriosis via openalex

[72] Pathophysiology, diagnosis and treatment of endometriosis. via openalex

[73] Peripheral biomarkers of endometriosis: a systematic review via openalex

[74] Peritoneal endometriosis, ovarian endometriosis, and adenomyotic nodules of the rectovaginal septum are three different entities via openalex

[75] Phytochemical analyses and effects of Alchemilla mollis (Buser) Rothm. and Alchemilla persica Rothm. in rat endometriosis model via openalex

[76] Potential involvement of hemoglobin and heme in the pathogenesis of peritoneal endometriosis via openalex

[77] Potential involvement of the immune system in the development of endometriosis via openalex

[78] Prediction of endometriosis with serum and peritoneal fluid markers: a prospective controlled trial via openalex

[79] Prodrug of green tea epigallocatechin-3-gallate (Pro-EGCG) as a potent anti-angiogenesis agent for endometriosis in mice via openalex

[80] Progestogens for endometriosis: forward to the past via openalex

[81] Puerarin Suppresses Invasion and Vascularization of Endometriosis Tissue Stimulated by 17β-Estradiol via openalex

[82] Puerarin Suppresses Proliferation of Endometriotic Stromal Cells Partly via the MAPK Signaling Pathway Induced by 17ß-estradiol-BSA via openalex

[83] Randomized controlled trial of depot leuprolide in patients with chronic pelvic pain and clinically suspected endometriosis via openalex

[84] Regression of Endometrial Implants by Resveratrol in an Experimentally Induced Endometriosis Model in Rats via openalex

[85] Resveratrol Inhibits Development of Experimental Endometriosis In Vivo and Reduces Endometrial Stromal Cell Invasiveness In Vitro1 via openalex

[86] Resveratrol is a potent inhibitor of vascularization and cell proliferation in experimental endometriosis via openalex

[87] Rich innervation of deep infiltrating endometriosis via openalex

[88] Selected food intake and risk of endometriosis via openalex

[89] Selective Progesterone Receptor Modulator Development and Use in the Treatment of Leiomyomata and Endometriosis via openalex

[90] Serum and cyst fluid levels of interleukin (IL) -6, IL-8 and tumour necrosis factor-alpha in women with endometriomas and benign and malignant cystic ovarian tumours via openalex

[91] Serum and peritoneal abnormalities in endometriosis: potential use as diagnostic markers. via openalex

[92] Serum interleukin-8 levels are elevated in patients with ovarian endometrioma via openalex

[93] Serum levels of VEGF and TNF-α and their association with C-reactive protein in patients with endometriosis via openalex

[94] Serum MicroRNA Biomarkers Regulated by Simvastatin in a Primate Model of Endometriosis via openalex

[95] Shikonin reduces endometriosis by inhibiting RANTES secretion and mononuclear macrophage chemotaxis via openalex

[96] Suppression of the Development of Experimentally Induced Uterine Adenomyosis by a Novel Matrix Metalloproteinase Inhibitor, ONO-4817, in Mice via openalex

[97] The observation of inhibition effect of ginsenoside Rg3 on endometriosis rats model via openalex

[98] The Pains of Endometriosis via openalex

[99] The performance of CA-125 measurement in the detection of endometriosis: a meta-analysis via openalex

[100] Therapeutic potential of andrographolide for treating endometriosis via openalex